# The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study

Study · id `cardio:ct-nct02973529` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02973529](<https://clinicaltrials.gov/study/NCT02973529>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02973529

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT02973529. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT02973529, source copy `cardio:ctgov-nct02973529-2026-01-02`, retrieved 2026-10-26)
- Start date: 2016-01 (registry gives no type) (ClinicalTrials.gov record NCT02973529, source copy `cardio:ctgov-nct02973529-2026-01-02`, retrieved 2026-10-26)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT02973529, source copy `cardio:ctgov-nct02973529-2026-01-02`, retrieved 2026-10-26)
- Completion: 2028-09 (anticipated) (ClinicalTrials.gov record NCT02973529, source copy `cardio:ctgov-nct02973529-2026-01-02`, retrieved 2026-10-26)
- Countries: Denmark; Latvia (ClinicalTrials.gov record NCT02973529, source copy `cardio:ctgov-nct02973529-2026-01-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02973529-2026-01-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
- Acronym: BIFSORB
- Condition: Coronary Artery Disease
- Intervention (Device): Absorb
- Intervention (Device): Desolve
- Lead sponsor: Aarhus University Hospital Skejby
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Aarhus University Hospital Skejby (`cardio:org-aarhus-university-hospital-skejby`)

## Provenance

Content hash: 417fedba6fec182f137962113e430f152b6b84a1f7f9685b2ae803a801063464
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
